Tag: Relay Therapeutics

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Relay Therapeutics

Relay Therapeutics Secures $63 Million in Series B Financing

Added to Collection on: 2017-12-13 20:00:00

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Relay Therapeutics Names Linda A. Hill, Ph.D., to Its Board of Directors

Added to Collection on: 2018-10-08 21:41:15

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Relay Therapeutics Secures $400 Million in Series C Financing

Added to Collection on: 2018-12-19 20:00:00

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Relay Therapeutics Names Imogen Pryce, Ph.D., Vice President of Strategy and Corporate Affairs

Added to Collection on: 2019-02-05 22:12:08

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Relay Therapeutics Names Doug Ingram and Deep Nishar to Its Board of Directors

Added to Collection on: 2019-07-17 06:52:30

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Relay Therapeutics Names Jami Rubin to Its Board of Directors

Added to Collection on: 2019-09-30 17:56:15

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Relay Therapeutics to Present at the 38th Annual JP Morgan Healthcare Conference

Added to Collection on: 2020-01-05 21:18:45

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Relay Therapeutics Appoints Dr. James Nichols to Lead Expansion into Genetic Diseases

Added to Collection on: 2020-02-03 19:03:45

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Arguing on AI Drug Discovery

Added to Collection on: 2020-02-03 22:48:45

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
The Goldman Sachs Group Lowers Relay Therapeutics (NASDAQ:RLAY) Price Target to $18.00

Added to Collection on: 2025-03-01 14:30:19

Tags for this article:

Click the tags to see associated articles and topics

View Article Details
Book a Demo